obesity drug news today october 21 2025 glp-1 Receptor Agonists – From Evolution to Revolution Outlook for obesity in 2025:
Description
This is the reason a higher A1c lowering effect is observed with GLP1 agonists, due to the FPG lowering effect
In terms of lowering HbA1c, dulaglutide, when administered once a week, was demonstrated to be more effective than exenatide twice a day, by 1.51% vs.0.99% [94]
Taheri H, Malek M, Ismail-Beigi F et al (2020) Effect of Empagliflozin on Liver Steatosis and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease Without Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
Have your prescription ready if asked
Sleep disturbance and anxiety can feel more pronounced
